Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Alcoa Q1 Profit Falls - Quick Facts

RELATED NEWS
Trade AA now with 

Alcoa Inc. (AA: Quote) reported that its first quarter 2012 net income attributable to the company was $94 million, or $0.09 per share, down from $308 million, or $0.27 per share in first quarter 2011.

Excluding the impact of special items, income from continuing operations for the latest-quarter was $105 million, or $0.10 per share. Special items in first quarter 2012 included the negative impact of mark-to-market changes on certain energy contracts and restructuring charges primarily related to smelter curtailments. Analysts polled by Thomson Reuters expected the company to report a loss of $0.04 per share for the quarter. Analysts' estimates typically exclude special items.

Sales for the quarter rose to $6.01 billion from $5.96 billion in the prior year quarter. Twelve analysts had consensus revenue estimate of $5.77 billion for the quarter.

Alcoa said that it continues to project a global aluminum supply deficit in 2012 and reaffirmed its forecast that global aluminum demand would grow 7 percent in 2012, on top of the 10 percent growth seen in 2011.

Alcoa raised its 2012 global growth forecast for the aerospace market 3 percentage points (13-14 percent).

Click here to receive FREE breaking news email alerts for Alcoa Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Proctor and Gamble (PG) has sold two of its soap brands to European consumer products giant Unilever (UN). Cincinnati-based P&G says the sale includes the global Camay brand, the Zest brand outside of North America and its Talisman manufacturing plant in Mexico. The plant employs approximately... Dish Network is no longer carrying Fox News in yet another dispute for the television provider. Fox News, which changed the face of cable news with its ardent advocacy of conservative issues, went dark Sunday, replaced on Dish by The Blaze, Glen Beck's new right-leaning channel. Fox Business channel... Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.